Related Experiment Video
Updated: May 27, 2026

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
Unrecognized visual field deficits in children with primary central nervous system brain tumors
M J Harbert1, L A Yeh-Nayre, H S O'Halloran
1Department of Neurosciences, University of California, San Diego and Rady Children's Hospital, San Diego, USA.
Insights
Many children with brain tumors have undetected visual field deficits, often missed by patients or caregivers. Regular neuro-ophthalmologic exams are crucial for early detection in pediatric brain tumor patients.
Area of Science:
- Pediatric Neurology
- Neuro-Ophthalmology
- Oncology
Background:
- Visual field deficits are potential complications of brain tumors and their treatments.
- The prevalence of unrecognized visual field deficits in pediatric brain tumor patients is unknown.
Purpose of the Study:
- To determine the prevalence of undiagnosed visual field deficits in children with primary brain tumors.
- To identify potential causes and locations of these deficits.
Main Methods:
- Prospective study of 92 children with primary brain tumors at a pediatric hospital.
- Children underwent neuro-ophthalmologic examinations over 16 months.
- Exclusion criteria included optic glioma, craniopharyngioma, or pre-existing deficits.
Main Results:
- 15.2% (14/92) of children had undiagnosed visual field deficits.
- Deficits were linked to tumor infiltration (8), surgery (5), or radiation (1).
- Temporal lobe tumors were significantly associated with visual field deficits (P=0.004).
Conclusions:
- A significant number of children with brain tumors have unrecognized visual field deficits.
- These deficits are often asymptomatic and not reported by patients or caregivers.
- Routine neuro-ophthalmologic evaluations are essential for timely diagnosis in this population.
Abstract:
Visual field deficits can be a consequence of brain tumor location or treatment. The prevalence of unrecognized visual field deficits in children diagnosed with brain tumors is not known. All children at a single tertiary care pediatric children's hospital diagnosed with a primary brain tumor were tested for visual field deficits by a child neurologist and neuro-ophthalmologist over 16 months. Children with reproducible visual field deficits on two separate occasions were included in the analysis. Patients with optic glioma, craniopharyngioma, or previously known visual field deficits were excluded. Fourteen of 92 (15.2%) children (average 8.9 years, 8 girls) had undiagnosed visual field deficits. Average time between diagnosis of tumor and unrecognized visual field deficit was 3.7 years (range 0-13 years). Unrecognized visual field deficits were not associated with age (P = 0.27) or gender (P = 0.38). Visual field deficits were attributed to direct tumor infiltration (n = 8), postoperative complications (n = 5) and post-radiation edema (n = 1). Deficits included bitemporal hemianopsia (n = 2), homonymous hemianopsia (n = 9), quadrantanopsia (n = 2), and concentric visual field loss (n = 1.) Tumor location included temporal lobe (n = 9), parietal lobe (n = 2), posterior fossa (n = 2), hypothalamic-chiasmatic (n = 2) and multifocal areas (n = 4). Children with temporal lobe tumors were more likely to have unrecognized visual field deficits (P = 0.004). In all 14 patients, visual field deficits were determined by examination only and were not reported by either the patient or caregiver regardless of age. The prevalence of unrecognized visual field deficits in children with brain tumors can be surprisingly high. Serial neuro-ophthalmologic evaluation of children with brain tumors is often required to diagnose a visual field deficit since patient or caregiver reporting may be limited.
Related Concept Videos
Prosopagnosia
Visual Agnosia

